A small number of cancers (basal cell carcinoma, breast cancer, malignant melanoma, lipoma, squamous cell carcinoma) were reported during the 12-week oral METAOD005 trial
Our medical team can guide you based on your health goals
No more long queues and extensive wait time, choose injection and vaccination services at home that offer safe, effective and timely care in Noida
As it is classified as a research peptide, BPC-157 is not approved by the FDA for general therapeutic use
The animal evidence is consistent with the mechanistic findings
Dosing is individualized based on patient needs, treatment goals, and provider assessment